XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 26.56

+3.5%

2:49 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Thomas J Pittman who wrote (11229)	8/16/1999 5:29:00 PM
From: Thomas J Pittman	Read Replies (2) of 17367

Trauma study ongoing. Some results???missed it??? in September? HU111: old stuff about GENE large market, phase 3 to start in 4Q, hope to have more to say 'shortly'. Other products Allergan nothing new, Allergan to fund all development costs, XOMA gets percentage of sales. mentioned orally take bpi, didnt get what it was working on bpi in many areas including tumors talking to potential partners ........

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next